AU2001259627A1 - Cell line for the expression of an alpha2delta2 calcium channel subunit - Google Patents
Cell line for the expression of an alpha2delta2 calcium channel subunitInfo
- Publication number
- AU2001259627A1 AU2001259627A1 AU2001259627A AU5962701A AU2001259627A1 AU 2001259627 A1 AU2001259627 A1 AU 2001259627A1 AU 2001259627 A AU2001259627 A AU 2001259627A AU 5962701 A AU5962701 A AU 5962701A AU 2001259627 A1 AU2001259627 A1 AU 2001259627A1
- Authority
- AU
- Australia
- Prior art keywords
- expression
- cell line
- calcium channel
- channel subunit
- subunit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9406—Neurotransmitters
- G01N33/9426—GABA, i.e. gamma-amino-butyrate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
- C12N2503/02—Drug screening
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20446600P | 2000-05-16 | 2000-05-16 | |
US60/204,466 | 2000-05-16 | ||
PCT/US2001/014799 WO2001088101A2 (en) | 2000-05-16 | 2001-05-08 | CELL LINE FOR THE EXPRESSION OF AN α2δ2 CALCIUM CHANNEL SUBUNIT |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001259627A1 true AU2001259627A1 (en) | 2001-11-26 |
Family
ID=22758003
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001259627A Abandoned AU2001259627A1 (en) | 2000-05-16 | 2001-05-08 | Cell line for the expression of an alpha2delta2 calcium channel subunit |
Country Status (6)
Country | Link |
---|---|
US (1) | US7067262B2 (en) |
EP (1) | EP1294854A2 (en) |
JP (1) | JP2003533223A (en) |
AU (1) | AU2001259627A1 (en) |
CA (1) | CA2408246A1 (en) |
WO (1) | WO2001088101A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL189872B1 (en) | 1996-07-24 | 2005-10-31 | Warner Lambert Co | Isobutylgabe and its derivatives useful in relieving pains |
NI200300043A (en) * | 2002-03-28 | 2003-11-05 | Warner Lambert Co | AMINO ACIDS WITH AFFINITY FOR THE PROTEIN a2DELTA. |
WO2005030703A1 (en) | 2003-09-25 | 2005-04-07 | Warner-Lambert Company Llc | PRODRUGS OF AMINO ACIDS WITH AFFINITY FOR THE α2δ- PROTEIN |
EP2116618A1 (en) | 2008-05-09 | 2009-11-11 | Agency for Science, Technology And Research | Diagnosis and treatment of Kawasaki disease |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5712158A (en) | 1995-06-06 | 1998-01-27 | Warner-Lambert Company | Cell line for the rapid expression of functional calcium channels |
WO1999008670A1 (en) | 1997-08-20 | 1999-02-25 | Guglietta, Antonio | Gaba analogs to prevent and treat gastrointestinal damage |
-
2001
- 2001-05-08 JP JP2001585309A patent/JP2003533223A/en active Pending
- 2001-05-08 WO PCT/US2001/014799 patent/WO2001088101A2/en not_active Application Discontinuation
- 2001-05-08 CA CA002408246A patent/CA2408246A1/en not_active Abandoned
- 2001-05-08 AU AU2001259627A patent/AU2001259627A1/en not_active Abandoned
- 2001-05-08 EP EP01933183A patent/EP1294854A2/en not_active Withdrawn
- 2001-05-08 US US10/258,936 patent/US7067262B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2001088101A2 (en) | 2001-11-22 |
WO2001088101A3 (en) | 2002-08-08 |
JP2003533223A (en) | 2003-11-11 |
CA2408246A1 (en) | 2001-11-22 |
EP1294854A2 (en) | 2003-03-26 |
US20030212132A1 (en) | 2003-11-13 |
US7067262B2 (en) | 2006-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001264256A1 (en) | Plaster | |
AU2001276031A1 (en) | Branded channel | |
AU9517301A (en) | Implant | |
EP1130098A3 (en) | Mammalian osteoregulins | |
AU2001286927A1 (en) | Serving dynamic web-pages | |
AU2001252679A1 (en) | Plaster | |
AU2001263841A1 (en) | Implant | |
AU2001265089A1 (en) | Rc-timer scheme | |
AU3942901A (en) | Navigational aid | |
AU5818000A (en) | Speech bandwidth expansion | |
AU2002220553A1 (en) | Bioreactor | |
AU2002234010A1 (en) | Benzamidine derivatives | |
AU2001290529A1 (en) | Marital aid | |
AU2001295793A1 (en) | Pluripotential stem cells | |
AU2001290078A1 (en) | Stem cell therapy | |
AU2001234458A1 (en) | Note feeder | |
AU2001292786A1 (en) | Sulfur-containing cathode | |
AU2002249809A1 (en) | Potassium channel inhibitors | |
AU2001290402A1 (en) | Channel time calibration means | |
AU2203901A (en) | Microporous membrane | |
AU2001220281A1 (en) | Rollerboard for road-skiing | |
AU2001250966A1 (en) | Pluripotential stem cells | |
AU2001240557A1 (en) | Implant for cranioplastics | |
AU2001259627A1 (en) | Cell line for the expression of an alpha2delta2 calcium channel subunit | |
AU2001294010A1 (en) | Stem cells |